ABSA International
ABSA International

Resources with keywords: covid-19



Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021 (Website, Publication)
CDC / Emerging Infectious Diseases
1 July 2023

Gold J, Adjei S, Gundlapalli AV, Huang YA, Chiller T, Benedict K, et al.
COVID-19 infection is a substantial risk factor for certain fungal infections, particularly those caused by invasive molds.

Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada (Website, Publication)
CDC / Emerging Infectious Diseases
28 June 2023

Cheng L, Dhiyebi H, Varia M, Atanas K, Srikanthan N, Hayat S, et al..
At the peak of the Omicron BA.2 outbreak in April 2022, reported COVID-19 cases were underestimated 19-fold because of changes in clinical testing.

Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023 (Website, Publication)
CDC/MMWR
16 June 2023

Moulia DL, Wallace M, Roper LE, et al.
Updated vaccine recommendations for children > 6 months and adults >65.

End of the Federal COVID-19 Public Health Emergency (PHE) Declaration
CDC

The federal COVID-19 PHE declaration ended on May 11, 2023.

CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the updated vaccine
CDC
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months–5 Years — United States, June 17, 2022–May 7, 2023 (Website, Publication)
CDC/MMWR
9 June 2023

Hause AM, Marquez P, Zhang B, et al.

Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators ― United States, October 1, 2020–March 22, 2023
CDC/MMWR
12 May 2023

Scobie HM, Panaggio M, Binder AM, et al.
Surveillance data from October 1, 2020–March 22, 2023

COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023
CDC/MMWR
12 May 2023

Silk BJ, Scobie HM, Duck WM, et al.
The authors indicate the following: “Changes to the national COVID-19 monitoring strategy and COVID Data Tracker capitalize on marked improvements in multiple surveillance systems.”

Persistent prosopagnosia following COVID-19
Science Direct
1 May 2023

Kieseler ML, Duchaine B
Long covid effects may include the inability to recgonize faces.

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023
CDC/MMWR
28 April 2023

DeCuir J, Surie D, Zhu Y, et al.

Go to Top